226 related articles for article (PubMed ID: 29422643)
1. RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment.
Lin KH; Huang MY; Cheng WC; Wang SC; Fang SH; Tu HP; Su CC; Hung YL; Liu PL; Chen CS; Wang YT; Li CY
Sci Rep; 2018 Feb; 8(1):2672. PubMed ID: 29422643
[TBL] [Abstract][Full Text] [Related]
2. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
3. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
Li MY; Mi C; Wang KS; Wang Z; Zuo HX; Piao LX; Xu GH; Li X; Ma J; Jin X
Chem Biol Interact; 2017 Aug; 274():58-67. PubMed ID: 28684144
[TBL] [Abstract][Full Text] [Related]
4. Shikonin induces apoptosis and prosurvival autophagy in human melanoma A375 cells via ROS-mediated ER stress and p38 pathways.
Liu Y; Kang X; Niu G; He S; Zhang T; Bai Y; Li Y; Hao H; Chen C; Shou Z; Li B
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):626-635. PubMed ID: 30873870
[TBL] [Abstract][Full Text] [Related]
5. Shikonin induces cell cycle arrest in human gastric cancer (AGS) by early growth response 1 (Egr1)-mediated p21 gene expression.
Kim SJ; Kim JM; Shim SH; Chang HI
J Ethnopharmacol; 2014 Feb; 151(3):1064-1071. PubMed ID: 24384380
[TBL] [Abstract][Full Text] [Related]
6. RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway.
Shahsavari Z; Karami-Tehrani F; Salami S; Ghasemzadeh M
Tumour Biol; 2016 Apr; 37(4):4479-91. PubMed ID: 26496737
[TBL] [Abstract][Full Text] [Related]
7. Shikonin reactivates TSGs GADD45B and PPP3CC to block NSCLC cell proliferation and migration through JNK/P38/MAPK signaling pathways.
Zhao Y; Wu D; Fu Z; Liu W; Yao Y; Liang Y
BMC Complement Med Ther; 2024 Jan; 24(1):10. PubMed ID: 38167059
[TBL] [Abstract][Full Text] [Related]
8. Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways.
Jing H; Sun W; Fan J; Zhang Y; Yang J; Jia J; Li J; Guo J; Luo S; Zheng Y
Mol Med Rep; 2016 Apr; 13(4):3009-16. PubMed ID: 26935874
[TBL] [Abstract][Full Text] [Related]
9. Shikonin induces apoptosis and G0/G1 phase arrest of gallbladder cancer cells via the JNK signaling pathway.
Zhai T; Hei Z; Ma Q; Liang H; Xu Y; Zhang Y; Jin L; Han C; Wang J
Oncol Rep; 2017 Dec; 38(6):3473-3480. PubMed ID: 29039581
[TBL] [Abstract][Full Text] [Related]
10. Shikonin Inhibits the Proliferation of Human Breast Cancer Cells by Reducing Tumor-Derived Exosomes.
Wei Y; Li M; Cui S; Wang D; Zhang CY; Zen K; Li L
Molecules; 2016 Jun; 21(6):. PubMed ID: 27322220
[TBL] [Abstract][Full Text] [Related]
11. Shikonin, an ingredient of Lithospermum erythrorhizon, down-regulates the expression of steroid sulfatase genes in breast cancer cells.
Zhang Y; Qian RQ; Li PP
Cancer Lett; 2009 Oct; 284(1):47-54. PubMed ID: 19419812
[TBL] [Abstract][Full Text] [Related]
12. Targeting Cell Necroptosis and Apoptosis Induced by Shikonin via Receptor Interacting Protein Kinases in Estrogen Receptor Positive Breast Cancer Cell Line, MCF-7.
Shahsavari Z; Karami-Tehrani F; Salami S
Anticancer Agents Med Chem; 2018; 18(2):245-254. PubMed ID: 28933271
[TBL] [Abstract][Full Text] [Related]
13. Shikonin inhibits TNF-α-induced growth and invasion of rat aortic vascular smooth muscle cells.
Zhang X; Hu W; Wu F; Yuan X; Hu J
Can J Physiol Pharmacol; 2015 Aug; 93(8):615-24. PubMed ID: 26042337
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21(Cip1) downregulation are required for shikonin-induced apoptosis.
Ahn J; Won M; Choi JH; Kim YS; Jung CR; Im DS; Kyun ML; Lee K; Song KB; Chung KS
Apoptosis; 2013 Jul; 18(7):870-81. PubMed ID: 23546866
[TBL] [Abstract][Full Text] [Related]
15. Effect of shikonin on human breast cancer cells proliferation and apoptosis in vitro.
Hou Y; Guo T; Wu C; He X; Zhao M
Yakugaku Zasshi; 2006 Dec; 126(12):1383-6. PubMed ID: 17139164
[TBL] [Abstract][Full Text] [Related]
16. Shikonin inhibits cancer cell cycling by targeting Cdc25s.
Zhang S; Gao Q; Li W; Zhu L; Shang Q; Feng S; Jia J; Jia Q; Shen S; Su Z
BMC Cancer; 2019 Jan; 19(1):20. PubMed ID: 30616572
[TBL] [Abstract][Full Text] [Related]
17. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.
Yang Q; Ji M; Guan H; Shi B; Hou P
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1909-17. PubMed ID: 24106286
[TBL] [Abstract][Full Text] [Related]
18. Comparative Proteomic Analysis of Lithospermum erythrorhizon Reveals Regulation of a Variety of Metabolic Enzymes Leading to Comprehensive Understanding of the Shikonin Biosynthetic Pathway.
Takanashi K; Nakagawa Y; Aburaya S; Kaminade K; Aoki W; Saida-Munakata Y; Sugiyama A; Ueda M; Yazaki K
Plant Cell Physiol; 2019 Jan; 60(1):19-28. PubMed ID: 30169873
[TBL] [Abstract][Full Text] [Related]
19. Shikonin inhibits proliferation of melanoma cells by MAPK pathway-mediated induction of apoptosis.
Lee JH; Han SH; Kim YM; Kim SH; Yoo ES; Woo JS; Jung GH; Jung SH; Kim BS; Jung JY
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33403388
[TBL] [Abstract][Full Text] [Related]
20. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
